Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Egalet Corp (NASDAQ:EGLT)

7.61
Delayed Data
As of Sep 30
 -0.10 / -1.30%
Today’s Change
4.34
Today|||52-Week Range
13.32
-30.94%
Year-to-Date
No recent news for Egalet Corp.

Today’s Trading

Previous close7.71
Today’s open7.72
Day’s range7.40 - 7.83
Volume351,538
Average volume (3 months)213,537
Market cap$191.2M
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+1.01%
Earnings growth (this year)-18.48%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,089.06%
P/E ratioNM
Price/Sales9.53
Price/Book2.14

Competitors

 Today’s
change
Today’s
% change
DRRXDURECT Corp+0.05+3.73%
VTLVital Therapies Inc+0.04+0.66%
IMDZImmune Design Corp+0.27+3.69%
ABUSArbutus Biopharma Co...-0.45-11.57%
Data as of 4:00pm ET, 09/30/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$0.89
Annual revenue (last year)$22.8M
Annual profit (last year)-$57.9M
Net profit margin-253.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Robert Samuel Radie
Chief Operating Officer &
Executive VP
Mark Strobeck
Corporate headquarters
Wayne, Pennsylvania

Forecasts

Search for Jobs